What is Sonoma Pharmaceuticals, Inc. Common Stock's Market Cap?

Sonoma Pharmaceuticals, Inc. Common Stock's Market Cap is $6.4M, based on as-reported figures from SEC (XBRL) filings.

What is Sonoma Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Sonoma Pharmaceuticals, Inc. Common Stock's Enterprise Value is $1.2M, based on as-reported figures from SEC (XBRL) filings.

What is Sonoma Pharmaceuticals, Inc. Common Stock's Price / Sales?

Sonoma Pharmaceuticals, Inc. Common Stock's Price / Sales is 0.3×, based on as-reported figures from SEC (XBRL) filings.

What is Sonoma Pharmaceuticals, Inc. Common Stock's EV / Revenue?

Sonoma Pharmaceuticals, Inc. Common Stock's EV / Revenue is 0.1×, based on as-reported figures from SEC (XBRL) filings.

What is Sonoma Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Sonoma Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Sonoma Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?

Sonoma Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $21.9M, based on as-reported figures from SEC (XBRL) filings.

What is Sonoma Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Sonoma Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$2.3M, based on as-reported figures from SEC (XBRL) filings.

What is Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA?

Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA is -$1.3M, based on as-reported figures from SEC (XBRL) filings.

What is Sonoma Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Sonoma Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -0.47, based on as-reported figures from SEC (XBRL) filings.

What is Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA Margin?

Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -5.8%, based on as-reported figures from SEC (XBRL) filings.

Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) Financial Statements

Sonoma Pharmaceuticals, Inc. Common Stock

SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

FIGI BBG001SQ8K88

XNAS · usd

1.33▲ 0.01 (0.38%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close1.33

Day's Range1.31 – 1.36

52-Week Range0.85 – 4.70

Volume43.5K

Avg Volume175.7K

Share Statistics

Shares Outstanding

Employees168

ExchangeXNAS

Listed2007-01-25

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Sonoma Pharmaceuticals, Inc. Common Stock (SNOA)

What is Sonoma Pharmaceuticals, Inc. Common Stock's Market Cap?: Sonoma Pharmaceuticals, Inc. Common Stock's Market Cap is $6.4M, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Sonoma Pharmaceuticals, Inc. Common Stock's Enterprise Value is $1.2M, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's Price / Sales?: Sonoma Pharmaceuticals, Inc. Common Stock's Price / Sales is 0.3×, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's EV / Revenue?: Sonoma Pharmaceuticals, Inc. Common Stock's EV / Revenue is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Sonoma Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?: Sonoma Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $21.9M, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Sonoma Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$2.3M, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA?: Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA is -$1.3M, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Sonoma Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -0.47, based on as-reported figures from SEC (XBRL) filings.
What is Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA Margin?: Sonoma Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -5.8%, based on as-reported figures from SEC (XBRL) filings.